Good day,
Thank you for subscribing to the Earnings360 newsletter, your daily source for quarterly earnings news and updates.
Each morning edition contains a wrap-up of today's pre-market earnings announcements and yesterday's earnings announcements after the closing bell.
Before we send you your first edition, please take a moment to confirm your subscription below. We will not be able to send your newsletter until you confirm your subscription.
Confirm Your Subscription Here
The Earnings360 Team
Thursday's Bonus Story The Best AI for Picking Stocks, Ranked by PerformanceWritten by Thomas Hughes. Published 10/22/2025. 
Key Points - Seven AI models and 30 humans picked one unique stock under identical rules, aiming for the highest return on a $1,000 investment over three months.
- ChatGPT selected the top-performing stock of all the AI picks, while other AI stock choices delivered mixed results.
- In the end, a human pick outperformed all others.
Ever wonder which AI model is best at picking stocks? So did the team at MarketBeat. We organized a lighthearted contest to find out, and the results may surprise you. Below are the seven leading AI models, the stocks they selected and how those picks performed. AI Stock Picking Contest Parameters Something unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted Cruz calling the White House a "mafia," and even Trump's approval rating slipping. But veteran analyst Porter Stansberry says this isn't really about politics at all. It's part of a much larger shift he calls The Final Displacement — a historic economic and social realignment already impacting millions of Americans. His new documentary explains what's driving it and how to prepare before it accelerates further. Watch The Final Displacement to see what's really happening behind the scenes Seven popular AI models—ChatGPT, ChatGPT Deep Research, Claude Opus, Claude Sonnet, Gemini, Grok, and Perplexity—alongside 30 humans were asked to submit stock picks under the same rules to provide a broad comparison. The rules of the contest were simple: - Choose one stock listed on the NYSE, NASDAQ, TSE, or LON only.
- Exclude ETFs, crypto, and mutual funds.
- Avoid duplicate picks (you could not pick stocks already chosen by another participant).
- Select the stock you believe will deliver the greatest percentage gain on a $1,000 investment between the market close on July 21 and the market close on October 21.
1. ChatGPT: SoundHound's 55.7% Gain ChatGPT, the original AI model that sparked the recent wave of interest, placed 7th overall and was the top performer among the AI entries. ChatGPT stands out for producing coherent, conversational output and maintaining context while adapting to prompts. For the contest, ChatGPT picked SoundHound AI (NASDAQ: SOUN), which gained about 56% over the period on enthusiasm for real-world AI applications and new commercial partnerships. SoundHound is a leader in voice-actuated AI and a speech-to-meaning approach that enables faster, more accurate translations and conversational interfaces. 
2. Claude Sonnet: ASTS Space Mobile's 38.7% Gain Claude Sonnet, known for its balance of conversational fluency, reasoning, and coding skills, picked ASTS Space Mobile (NASDAQ: ASTS), producing a nearly 39% gain. It was the second-best AI pick and finished 13th overall. ASTS is notable for its role in the mobile industry and a rapidly expanding satellite network. The company forecasts near-complete coverage of critical Northern Hemisphere markets within the next two years and a sharp revenue ramp that began this quarter. The analyst consensus predicts quadruple-digit year-over-year revenue growth, with acceleration over the next several quarters and sustained high triple-digit gains thereafter. Profitability is expected by 2027, and these estimates may even be conservative. 3. ChatGPT Deep Research: Larimar Therapeutics' 31.9% Gain ChatGPT Deep Research is a variant of ChatGPT that delivers more extensive, research-style answers. This model placed third among the AI entries and 16th overall. It selected Larimar Therapeutics (NASDAQ: LRMR), which rose nearly 32% during the trial period. Larimar is a clinical-stage biopharma with several upcoming catalysts, including Phase III results, new research launches, and an expected BLA filing with hopes for accelerated approvals. The analyst consensus forecasts more than 300% upside, reflecting strong optimism for further price gains. 
4. Perplexity: Regencell Biosciences' 12.2% Gain Perplexity is an AI model often described as providing search-engine-like answers. It synthesizes web sources and provides source context. Perplexity finished fourth among AI entries and 21st overall, picking Regencell Biosciences (NASDAQ: RGC), which gained about 12%. Regencell is attempting to commercialize traditional Chinese medicine therapies for ADHD and autism but has little market support. The lone analyst tracked by MarketBeat rates the stock a Sell, institutions own under 0.5% of shares, and there are no clear catalysts on the horizon. 5. Gemini: Super Micro Computers' 6.5% Gain Google's Gemini, known for its multi-modality and integration with Google's ecosystem, chose Super Micro Computers (NASDAQ: SMCI). Gemini placed fifth among AI models and 23rd overall. Super Micro is well-positioned to benefit from an AI-driven surge in demand for GPU servers, though it has yet to show a sustained revenue boom. That could change with the upcoming earnings report. Until then, the stock has struggled with market confidence following last year's financial issues. The industry outlook suggests AI powerhouses plan to invest hundreds of billions in data centers over the next three to five years, and SMCI's GPU servers are likely to play a major role. 
6. Claude Opus: Replimune's 34.3% Loss Claude Opus, recognized for strong reasoning, multimodality, and contextual understanding, made a riskier choice by selecting Replimune Group (NASDAQ: REPL), despite high short interest and deteriorating analyst sentiment. Replimune fell more than 34%, placing Claude Opus sixth among the AI models and third-to-last overall. Replimune focuses on oncolytic therapies for cancer. Its outlook is challenged: a recent BLA submission was denied and, although resubmitted, market sentiment remains weak. Analyst sentiment has slipped from Buy to Reduce, and downward price-target revisions are weighing on the stock. 7. Grok: MoonLake Immunotherapies' 82.9% Loss Grok finished last among both AI entries and all participants. Better known for its personality and edgy tone, Grok uses real-time data from X to inform its answers. Its pick, MoonLake Immunotherapies (NASDAQ: MLTX), plunged nearly 83% during the contest. MoonLake, which develops immunotherapies for autoimmune and inflammatory diseases, released mixed trial results on Sept. 29—midway through the contest—that set back its programs. The market reacted with a wave of downgrades and price-target cuts, sending the share price into the single-digit range. 
The Real Winner: A Human While AI can be useful for stock selection, it doesn't always outperform humans. The contest's top performer was a human, who picked Hut 8 Corp. (NASDAQ: HUT). Shares of the bitcoin-mining and high-performance computing company Hut 8 soared 120.15% during the contest period. The outcome underscores a key point: AI is a powerful tool, but it hasn't yet replaced human intuition, experience and discretionary research.
| 
